Literature DB >> 21354448

Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: results of a survey in 387 patients.

Martine Piarroux1, Renaud Piarroux, Roch Giorgi, Jenny Knapp, Karine Bardonnet, Bertrand Sudre, Jérôme Watelet, Jérôme Dumortier, Alain Gérard, Jean Beytout, Armand Abergel, Georges Mantion, Dominique A Vuitton, Solange Bresson-Hadni.   

Abstract

BACKGROUND & AIMS: Alveolar echinococcosis (AE) is a rare disease in humans, caused by the larval stage of the fox tapeworm Echinococcus multilocularis.
METHODS: We present here 387 detailed AE cases diagnosed in France from 1982 to 2007 actively identified by a retrospective survey performed in 1997-1998 and prospectively thereafter.
RESULTS: Male:female ratio was 1.03 and mean age 57.8 years at time of diagnosis. Among the 362 complete files (including 347 non dead-out and 15 dead-out lesions), 73% of the patients were symptomatic at first admittance. Among them, 83% presented with clinical patterns evocative either of a digestive or a hepatic disorder. Other symptomatic patients presented with erratic clinical pictures, generally due to metastasis or extra-hepatic location of the parasite. Except for a few patients with particularly severe AE who died shortly after the diagnosis, most patients were treated using benzimidazoles. Their mortality tends to merge with that of the general French population, matched by sex, age, and calendar year. This study also highlights an unexpectedly high frequency of blood-tied family cases (13% of patients submitted to a specific questionnaire).
CONCLUSIONS: Even though the broad set of clinical features provoked by E. multilocularis makes AE a potential diagnostic trap for many physicians, our study revealed an improvement of its prognosis. However, as shown by our findings about the frequency of family cases, there is still a need for studies aimed at better describing this uncommon parasitic disease.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354448     DOI: 10.1016/j.jhep.2011.02.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  35 in total

1.  Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification-ultrasound.

Authors:  Wolfgang Kratzer; Beate Gruener; Tanja E M Kaltenbach; Sarina Ansari-Bitzenberger; Peter Kern; Michael Fuchs; Richard A Mason; Thomas F E Barth; Mark M Haenle; Andreas Hillenbrand; Suemeyra Oeztuerk; Tilmann Graeter
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

2.  Acoustic structure quantification (ASQ): a new tool in sonographic examination of liver lesions in hepatic alveolar echinococcosis.

Authors:  Tanja Eva-Maria Kaltenbach; Beate Gruener; Atilla Serif Akinli; Wolfgang Kratzer; Suemeyra Oeztuerk; Richard Andrew Mason; Mark Martin Haenle; Tilmann Graeter
Journal:  J Med Ultrason (2001)       Date:  2014-05-01       Impact factor: 1.314

3.  [What comes on its own, goes on its own? : Case report of an infiltrating liver tumor growing over 16 years].

Authors:  J Wurlitzer; P Nguyen; S Hippe; V Wiechmann; M Dörne; A Weimann
Journal:  Chirurg       Date:  2019-04       Impact factor: 0.955

Review 4.  Multimodality imaging in diagnosis and management of alveolar echinococcosis: an update.

Authors:  Mesut Bulakçı; Merve Gülbiz Kartal; Sabri Yılmaz; Erdem Yılmaz; Ravza Yılmaz; Dilek Şahin; Murat Aşık; Oğuz Bülent Erol
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

5.  A report on three patients with Echinococcus multilocularis: Lessons learned.

Authors:  Nalini Bansal; Vivek Vij; Mukul Rastogi; Manav Wadhawan; Ajay Kumar
Journal:  Indian J Gastroenterol       Date:  2018-08-18

6.  In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes.

Authors:  Tatiana Küster; Nadja Kriegel; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

7.  An Echinococcus multilocularis Antigen B3 Proteoform That Shows Specific Antibody Responses to Active-Stage Alveolar Echinococcosis.

Authors:  Chun-Seob Ahn; Huixia Cai; Jeong-Geun Kim; Xiumin Han; Xiao Ma; Young-An Bae; Hyun-Jong Yang; Insug Kang; Hu Wang; Yoon Kong
Journal:  J Clin Microbiol       Date:  2015-08-12       Impact factor: 5.948

8.  A case of Budd-Chiari syndrome associated with alveolar echinococcosis.

Authors:  Erol Çakmak; Hakan Alagozlu; Cesur Gumus; Celiksöz Alí
Journal:  Korean J Parasitol       Date:  2013-08-30       Impact factor: 1.341

9.  Long-term Follow-up of a Patient with Portal Hypertension and Hepatic Failure Due to Hepatic Hydatid Disease.

Authors:  Yuki Takenaka; Tomomi Kogiso; Yuri Ogasawara; Miki Koroku; Sho Yatsuji; Makiko Taniai; Shinichi Nakamura; Katsutoshi Tokushige
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

10.  30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient.

Authors:  Karine Bardonnet; Dominique A Vuitton; Frédéric Grenouillet; Georges A Mantion; Eric Delabrousse; Oleg Blagosklonov; Jean-Philippe Miguet; Solange Bresson-Hadni
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-01-02       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.